Bladder Cancer,Genitourinary Cancer EV+P Improves Survival in LA/mUC: Compliance Impact Evaluated May 31, 2024
Bladder Cancer,Genitourinary Cancer Economic Impact on MIBC Treatment and Patient Survival May 29, 2024
Bladder Cancer,Genitourinary Cancer RC48 Alone or With Tislelizumab Shows Promise for NMIBC May 22, 2024
Bladder Cancer,Genitourinary Cancer Efficacy of Nadofaragene Firadenovec in BCG-Unresponsive NMIBC May 10, 2024
